Cargando…
Intravenous injection of beta-amyloid seeds promotes cerebral amyloid angiopathy (CAA)
Seeding and spread of beta-amyloid (Aβ) pathologies have been considered to be based on prion-like mechanisms. However, limited transmissibility of Aβ seeding activity upon peripheral exposure would represent a key difference to prions, not only in terms of pathogenesis but also in terms of potentia...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836327/ https://www.ncbi.nlm.nih.gov/pubmed/29506560 http://dx.doi.org/10.1186/s40478-018-0511-7 |
_version_ | 1783303942031015936 |
---|---|
author | Burwinkel, Michael Lutzenberger, Manuel Heppner, Frank L. Schulz-Schaeffer, Walter Baier, Michael |
author_facet | Burwinkel, Michael Lutzenberger, Manuel Heppner, Frank L. Schulz-Schaeffer, Walter Baier, Michael |
author_sort | Burwinkel, Michael |
collection | PubMed |
description | Seeding and spread of beta-amyloid (Aβ) pathologies have been considered to be based on prion-like mechanisms. However, limited transmissibility of Aβ seeding activity upon peripheral exposure would represent a key difference to prions, not only in terms of pathogenesis but also in terms of potential transmission of disease. We partially characterized the seeded Aβ amyloidosis after intracerebral injection of various brain homogenates in APP/PS1 mice. One particularly seed-laden homogenate was selected to investigate the development of Aβ pathologies after intravenous exposure. We report here that a single intravenous injection of an Alzheimer disease patient’s-brain extract into APP/PS1 recipient mice led to cerebral amyloid angiopathy within 180 days post injection. Thus, vascular proteinopathies such as CAA are transmissible in mice via the intravenous route of peripheral exposure. |
format | Online Article Text |
id | pubmed-5836327 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-58363272018-03-07 Intravenous injection of beta-amyloid seeds promotes cerebral amyloid angiopathy (CAA) Burwinkel, Michael Lutzenberger, Manuel Heppner, Frank L. Schulz-Schaeffer, Walter Baier, Michael Acta Neuropathol Commun Research Seeding and spread of beta-amyloid (Aβ) pathologies have been considered to be based on prion-like mechanisms. However, limited transmissibility of Aβ seeding activity upon peripheral exposure would represent a key difference to prions, not only in terms of pathogenesis but also in terms of potential transmission of disease. We partially characterized the seeded Aβ amyloidosis after intracerebral injection of various brain homogenates in APP/PS1 mice. One particularly seed-laden homogenate was selected to investigate the development of Aβ pathologies after intravenous exposure. We report here that a single intravenous injection of an Alzheimer disease patient’s-brain extract into APP/PS1 recipient mice led to cerebral amyloid angiopathy within 180 days post injection. Thus, vascular proteinopathies such as CAA are transmissible in mice via the intravenous route of peripheral exposure. BioMed Central 2018-03-05 /pmc/articles/PMC5836327/ /pubmed/29506560 http://dx.doi.org/10.1186/s40478-018-0511-7 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Burwinkel, Michael Lutzenberger, Manuel Heppner, Frank L. Schulz-Schaeffer, Walter Baier, Michael Intravenous injection of beta-amyloid seeds promotes cerebral amyloid angiopathy (CAA) |
title | Intravenous injection of beta-amyloid seeds promotes cerebral amyloid angiopathy (CAA) |
title_full | Intravenous injection of beta-amyloid seeds promotes cerebral amyloid angiopathy (CAA) |
title_fullStr | Intravenous injection of beta-amyloid seeds promotes cerebral amyloid angiopathy (CAA) |
title_full_unstemmed | Intravenous injection of beta-amyloid seeds promotes cerebral amyloid angiopathy (CAA) |
title_short | Intravenous injection of beta-amyloid seeds promotes cerebral amyloid angiopathy (CAA) |
title_sort | intravenous injection of beta-amyloid seeds promotes cerebral amyloid angiopathy (caa) |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836327/ https://www.ncbi.nlm.nih.gov/pubmed/29506560 http://dx.doi.org/10.1186/s40478-018-0511-7 |
work_keys_str_mv | AT burwinkelmichael intravenousinjectionofbetaamyloidseedspromotescerebralamyloidangiopathycaa AT lutzenbergermanuel intravenousinjectionofbetaamyloidseedspromotescerebralamyloidangiopathycaa AT heppnerfrankl intravenousinjectionofbetaamyloidseedspromotescerebralamyloidangiopathycaa AT schulzschaefferwalter intravenousinjectionofbetaamyloidseedspromotescerebralamyloidangiopathycaa AT baiermichael intravenousinjectionofbetaamyloidseedspromotescerebralamyloidangiopathycaa |